Abeona Therapeutics Inc.

ABEO · NASDAQ

Official-source baseline for Abeona Therapeutics using SEC submissions, SEC company facts, the FY2025 10-K, latest available 10-Q, filed FY2025 results release, filed launch update, 2026 proxy materials, and FDA product approval sources.

Follow Add to Watchlist Ask Question

NASDAQ ABEO Coverage Bootstrap Biotechnology Gene Therapy Rare Disease

Latest ReportMay 13, 2026Abeona Therapeutics (ABEO) Coverage Bootstrap: ZEVASKYN launch execution, manufacturing, payer access, and cash runwayView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.